INTRODUCTION {#sec1}
============

Saccharomycotina is a subphylum of the Ascomycota. It contains a single class (Saccharomycetes), and is comprised mostly by yeasts that have naked asci, do not form fruiting bodies and can reproduce asexually by budding (Kurtzman, Fell and Boekhout [@bib33]). Many budding yeast species are normal components of the human microbiota, inhabit our immediate environment, and some of them are traditionally used to ferment food or beverages (e.g. the baker\'s yeast *Saccharomyces cerevisiae*). In addition, some yeasts are considered opportunistic pathogens because they can cause disease under certain circumstances such as weakening of the immune system. Such opportunistic pathogenic yeasts constitute an important medical problem of increasing incidence. Indeed, yeast pathogens have become a major source of life-threatening nosocomial (i.e. hospital-acquired) infections since the 1980s, which is in part explained by recent medical progress. For instance, modern medical care has increased the survival of persons that are susceptible to yeasts opportunistic pathogens, such as premature neonates, elderly people, immunocompromised patients, as well as patients undergoing immunosuppressive chemotherapy. On the other hand, reliance on catheters, large-spectrum antibiotics and surgery are all factors that favor the spread and colonization of pathogenic yeasts (Turner and Butler [@bib61]). Candidiasis is a medical term that refers to any superficial or invasive fungal infection caused by any type of *Candida* yeast. Despite recent advances, the mortality rates associated to invasive Candidiasis remain high at 30%--40%, and the treatment of such infections is complicated by the appearance of resistance to antifungals and the emergence of novel pathogenic species (Papon *et al*. [@bib42]). The *Candida* genus itself is a very complex and heterogeneous taxon comprised of over 160 anamorphic (i.e. asexual reproductive stage) species, of which teleomorphs (i.e. sexual reproductive forms) belong to at least 16 different genera including *Pichia, Debaryomyces* or *Saccharomyces* (Guarro, Gené and Stchigel [@bib25]). Thus, the *Candida* genus is poliphyletic and comprises species belonging to evolutionary distant clades. Given recent developments in fungal taxonomy, including increased reliance on genomic data and the 'one fungus, one name' rule (Hawksworth [@bib27]), many *Candida* species are being renamed and the whole genus will likely be completely revamped in the coming years (Brandt and Lockhart [@bib5]). Over 30 *Candida* (or formerly named *Candida*) species have been identified as etiological agents in candidiasis (Table [1](#tbl1){ref-type="table"}). Although incidence may vary from region to region, four species generally account for over 95% of the cases: *Candida albicans*, *C. glabrata*, *C. parapsilosis and C. tropicalis*, generally in this order (Pfaller and Diekema [@bib43]; Diekema *et al.*[@bib11]). After these four main players, other *Candida* species can be found as causative agents of candidiasis but with much lower incidence, followed by a growing list of species that are rarely found in infections, including single-case reports (Table [1](#tbl1){ref-type="table"}).

###### 

List of 31 species reported as agents of candidasis. They are roughly classified in three groups according to their clinical incidence. Most incidence data come from a global study involving 141 hospitals from 41 countries over 10 years (1997--2007) (Pfaller *et al.*[@bib45]). Species marked with an asterisk were not listed in that study because they had not been discriminated as a different species, or because they have been reported from few cases elsewhere. Names between brackets indicate the currently accepted names for each *Candida* species.

  Incidence                                                Species
  -------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Common agents of candidiasis (5%--70%)                   *Candida albicans, C. glabrata, C. parapsilosis, C. tropicalis*
  Rare but may be locally common (0.1%--3%)                *C. krusei (Pichia kudriavzevii), C. lusitanae (Clavispora lusitaniae), C. orthopsilosis\*, C. metapsilosis\*, C. guilliermondii (M. guilliermondii), C. kefyr (Kluyveromyces marxianus), C. inconspicua, C. famata* (synonym: *Debaryomyces hansenii*)*, C. rugosa, C. dubliniensis, C. norvegensis (Pichia norvegensis), C. nivariensis\*, C. bracarensis\**
  Rarely reported (\<0.1% including single-case reports)   *C. pelliculosa (Wickerhamomyces anomalus), C. subhashii\*, C. lipolytica (Yarrowia lipolytica), C. sake, C. apicola, C. zeylanoides, C. valida (Pichia membranifaciens), C. intermedia, C. pulcherrima (Metschnikovia pulcherrima), C. haemulonii (C. heamulonis), C. stellatoidea, C. utilis (Cyberlindnera jardinii), C. humicola (Asterotremella humicola), C. lambica (Pichia fermentans), C. ciferrii (Trichomonascus ciferrii), C. colliculosa (Torulaspora delbrueckii), C. holmii (Kazachstania exigua), C. marina (Cryptococcus marinus), C. sphaerica (Kluyveromyces lactis)*

As mentioned above, despite their common genus name and their shared ability to infect humans, *Candida* pathogenic species can belong to phylogenetically distinct clades, which also contain non-pathogenic relatives. For instance, *C. glabrata* is a common pathogen that is closely related to the non-pathogenic species *Saccharomyces cerevisiae*, and *C. parapsilosis* is clearly a distinct lineage to that of *C. albicans*, and is more closely related to the non-pathogenic *Lodderomyces elongisporus.* Similarly, although *C. tropicalis* is not distantly related to *C. albicans*, it is sister to non-pathogenic species such as *C. sojae*. This indicates that the emergence of pathogenesis towards humans has occurred several times independently. Importantly, it is as yet poorly understood whether these different pathogenic clades may exploit common infection strategies or use lineage-specific mechanisms, or a combination of both. In addition, within each pathogenic clade, there is a large variability of virulence phenotypes across different strains (e.g. hyper and hypovirulent strains), and even some pathogenic strains have been described for generally non-pathogenic species such as *S. cerevisiae* (Anoop *et al.*[@bib2]). For many of the pathogenic species, however, it is unclear whether the human body constitutes their major ecological niche or whether they are adapted to a variety of environments. In fact, it is remarkable how little we know about the ecology of most yeast species. Ultimately, differences in virulence across species and strains are related to changes at the genomic level, and thus comparative genomics constitutes a promising research avenue.

Recent progress in genomics has facilitated the completion of the genomic sequences from numerous *Candida* pathogenic species and their non-virulent relatives, as well as of multiple isolates from the same species. Here we review recent advances in the understanding of how virulence traits in the different clades may have emerged. First, we provide an introduction to the computational and experimental approaches that can be used to trace what evolutionary mechanisms may have played a role in the evolution of a virulence trait. Then, we survey recent efforts focused on the three most important clades, according to their incidence: *C. albicans*, *C. glabrata* and *C. parapsilosis*. Finally, we discuss future avenues, including the application of high-throughput sequencing, meta-genomics and population genomics, to understand the recent evolution and epidemiology of fungal pathogens.

COMPARATIVE GENOMICS AND PHYLOGENOMICS TO DISCOVER AND UNRAVEL THE ORIGINS OF VIRULENCE TRAITS {#sec2}
==============================================================================================

The comparison of genomes under an evolutionary perspective (i.e. phylogenomics) constitutes a very powerful tool to understand the function, origin and evolution of biological processes of interest (Eisen [@bib14]; Gabaldón [@bib18]; Gabaldon and Marcet-Houben [@bib20]). Given the widespread focus on pathogenesis, the genomes of virulent organisms have traditionally been the main target of whole genome sequencing projects. Comparison with non-pathogenic relatives constitutes a common strategy to identify and prioritize candidate virulence factors. In this respect the comparison of the pathogenic bacterium *Listeria monocytogenes*, with its non-pathogenic relative *L. innocua*, constitutes one of the first examples of the use of a comparative genomics approach to search for genes involved in virulence (Glaser *et al.*[@bib23]). In that study the researchers identified several species-specific genes, which were enriched in secreted or cell-wall proteins, including several known virulence factors that were found to be specific to *L. monocytogenes*. The basic rationale of this approach is simple. Related species are expected to share the genetic factors that determine their shared phenotypes, whereas they are expected to differ genetically in those genomic regions that determine their unique phenotypic characteristics. Differences in the presence and absence of genes is one obvious trait to focus on, and this approach has been shown to be extremely useful in pathogenic bacteria, where genomic islands, often transmitted across species through horizontal gene transfer, can determine the existence of pathogenicity to a given host, or of resistance to a certain spectrum of antibiotics (Gal-Mor and Finlay [@bib22]). Two main problems underlie this approach. First of all, the two compared species are likely to differ in many more phenotypes than the one that constitutes the focus of our attention (i.e. virulence). In addition, most of the differing phenotypes or adaptations are likely to be unknown to us. Therefore, genetic differences will comprise those involved in all these many phenotypic differences. This problem scales up with the genetic and phenotypic divergence of the species compared. A second problem of the gene content comparison approach is that gene gain and loss is only one way in which changes in phenotype can be driven. Gene duplications, genomic re-arrangements and discrete point mutations in coding or non-coding regions may all determine key changes in phenotype, and would pass unnoticed in simple gene-content comparisons.

Taking into account these considerations, the phylogenomic approaches used to understand the evolution of pathogenesis have evolved in two main directions (see Fig. [1](#fig1){ref-type="fig"}). On the one hand, the resolution of the comparison has increased by considering less divergent and a higher number of genomes. This includes genomes from more closely related species as well as several strains per species. On the other hand, the comparisons have developed into more sophisticated ones, including the study of large genomic re-arrangements as well as the detection of past evolutionary events through the use of a phylogenetic approach or the analyses of genomic variation. These methods include not only the detection of genes duplicated in a given lineage but also those under positive selection. This more detailed approach has been driven by parallel developments in genomics and computational methods.

![Schematic overview of comparative genomics methods to find virulence factors. In the center of the image a phylogenetic tree represents the evolutionary relationships between an idealized group of pathogenic and non-pathogenic species, where the ones drawn in red are pathogenic. Red stars indicate two points in the tree where virulence emerged. For species E, a list of strains is indicated on the right showing the presence of sequenced strains with different degrees of virulence. The boxes surrounding the tree indicate different kinds of analyses that can be performed to detect virulence traits. (**A**) Search for genomic re-arrangements. (**B**) Presence and absence of genes, shown as a table where the white squares represent missing genes and the gray and red square represent present genes. In addition, red squares indicate putative virulence factors. (**C**) Detection of differences between strains. Each arrow represents a gene. Red horizontal lines represent SNPs. (**D**) Detection of positive selection. Red horizontal lines represent non-synonymous SNPs and black horizontal lines represent synonymous SNPs. (**E**) Events that can be detected with the use of phylogenetic trees. Arrows represent genes. Gene duplication and loss is represented along with changes in gene order. (**F**) Gene expansions. Phylogenetic tree representing two independent expansion events in the pathogenic species. Expansion points are marked with a star.](fow064fig1){#fig1}

Recent sequencing of several *Candida* pathogens and their close non-pathogenic relatives has enabled the use of comparative genomics approaches to discover virulence factors and trace their evolutionary emergence. Some such examples will be highlighted in the following sections. Before applying a comparative genomics approach, however, it is necessary to obtain an evolutionary scenario in which the relationships between pathogenic and non-pathogenic species are clearly delineated. In the following section we provide an overview of the evolutionary relationships among *Candida* species.

*CANDIDA* PATHOGENS ARE PHYLOGENETICALLY DIVERSE {#sec3}
================================================

To provide a glimpse of the diversity of currently sequenced *Candida* species, we used a phylogenomics approach, based on the analysis of 516 shared orthologous genes, to reconstruct the evolutionary relationships of 71 Saccharomycotina species (Fig. [2](#fig2){ref-type="fig"}). We highlighted species currently named *Candida* and those whose anamorph name or synonym name are *Candida*, and marked in red those species that are well-established pathogens or those that are recognized as emerging fungal pathogens. As observed in the tree, *Candida* species are spread throughout the Saccharomycotina phylogeny, being present in most of the clades. In addition, *Candida* species are generally intermingled with species assigned to other genera, highlighting the polyphyly of the genus. Pathogenic species are mainly found in two different clades: the CTG group and the *Nakaseomyces* group (marked with blue dots on the tree). The only exception is *Candida krusei*, which branches close to the wine yeast *Brettanomyces bruxellensis*. Two other *Candida* species, *C. boidinii* and *C. parapolymorpha* (syn. *Ogataea parapolymorpha*), are found in the same clade as *C. krusei*, though both of them are considered non-pathogenic.

![Phylogenetic relationships among *Candida*. A total of 516 genes detected as single copy genes in *Saccharomyces* species (Marcet-Houben and Gabaldón [@bib35]) were used to perform a homology search against a proteome database formed by the 71 Saccharomycotina species included in the tree. A phylogenetic tree was reconstructed for each group of homologs using the phylome reconstruction pipeline (Huerta-Cepas *et al.*[@bib30]). Phylogenetic trees were examined with ETE (Huerta-Cepas, Dopazo and Gabaldón [@bib31]), species-specific duplications were deleted and one sequence belonging to the duplicated clade was randomly chosen to represent the clade. Trees that, after filtering, contained one-to-one orthologs in at least three-fourth of the species were retained and their alignments were concatenated. The final alignment contained 190 110 amino acid positions. The phylogenetic tree was reconstructed using RAxML with the PROTGAMMALG model (Stamatakis, Ludwig and Meier [@bib56]). Bootstraps were reconstructed using RAxML rapid bootstrap approach, supports below 100 are marked on the tree. For *Candida* species, red-colored leaves indicate pathogenic species while green-colored leaves indicate non-pathogenic species.](fow064fig2){#fig2}

The CTG clade comprises several species that have the particularity of using an alternative genetic code in which the CUG codon, typically used for leucine, has been reassigned to serine and is ambiguously translated in the cytoplasm (Santos *et al.*[@bib53]). Interestingly, a reassignment of the same codon to alanine has apparently occurred in the lineage leading to *Pachysolen tannophilus* (Mühlhausen and Kollmar [@bib38]), a distantly related yeast isolated from sulfite liquor. The CTG clade contains most of the pathogenic *Candida* species, including two of the three major candidiasis agents: *C. albicans* and *C. parapsilosis*. The group comprises many species and 19 have completely sequenced genomes. Out of the sequenced species nearly half (9) are from human pathogens. Rather than being monophyletic, pathogenic species appear interspersed within non-pathogenic ones, with at least six independent pathogenic lineages surrounded with non-pathogenic relatives. This includes (i) the clade containing *C. albicans* and *C. dublinensis*; (ii) a separate clade containing *C. tropicalis*, an emerging fungal pathogen which is naturally resistant to fluconazole and which is more closely related to the rarely pathogenic *C. sojae* than it is to *C. albicans* (Fig. [2](#fig2){ref-type="fig"}); (iii) the *C. parapsilosis* species clade, comprising *C. parapsilosis* and the close relatives *C. orthopsilosis* and *C. metapsilosis*; (iv) a lineage comprising *Meyerozyma guilliermondii* (*C. guilliermondii*), and its close non-pathogenic relative *M. caribbica* (*Candida fermentati*); (v) a lineage containing *Clavispora lusitaniae* (*Candida lusitaniae*), grouped with the plant-associated yeast *Metschnikowia fructicola*; and (vi) a separate branch with the multidrug resistant *C. auris.*

The second main group of pathogenic *Candida* species is the *Nakaseomyces*, which is more closely related to *Saccharomyces cerevisiae* (Gabaldón *et al.*[@bib21]). The *Nakaseomyces* indeed is one of the several so-called post-WGD (post whole genome duplication) lineages, a group of species that diverged from an ancestor that duplicated its genome entirely (Wolfe and Shields [@bib63]; Dujon [@bib12]). Importantly, it has now become apparent that this WGD was triggered by an interspecies hybridization event (Marcet-Houben and Gabaldón [@bib35]). The post-WGD clade is very diverse and contains many species of industrial interest, but is otherwise scarce in pathogenic species. Among the post-WGD clade, only the *Nakaseomyces* clade seems to be prone to present the ability to infect humans. It comprises three pathogenic species, with *C. glabrata* as the most well known and which ranks as the second-most common source of candidiasis worldwide. *Candida bracarensis* and *C. nivarensis* are two related emergent pathogens of growing incidence (Gabaldón and Carreté [@bib19]). The three pathogens within the *Nakaseomyces* are not monophyletic, indicating that they may represent two, or even three parallel events of emergence of pathogenesis (Gabaldón *et al.*[@bib21]).

Altogether, from a phylogenetic perspective, *Candida* species do not have a single evolutionary origin, and the genus is destined to be completely redefined if we are to adhere to taxonomic principles. From a clinical perspective, we should look at *Candida* pathogens as a diverse set of infectious agents, despite their shared generic name and the common denomination of candidiasis for their infections. Indeed, the phylogenetic divergence between the four most prevalent *Candida* species (*C. albicans*, *C. glabrata*, *C. parapsilosis* and *C. tropicalis*) is reflected in their phenotypic diversity (Brunke and Hube [@bib6]; Papon *et al.*[@bib42]).

Out of these four species, *C. albicans* is the one showing the highest morphological plasticity, being able to grow in the form of single cells (yeast form), pseudohyphae and true hyphae depending on the environment (Sudbery [@bib57]; Thompson, Carlisle and Kadosh [@bib60]; Modrzewska and Kurnatowski [@bib37]; Priest and Lorenz [@bib46]). In addition, *C. albicans* can switch to hyphal and pseudohyphal forms once phagocytosed and use filamentous growth to burst out and kill macrophages. From the other three species, only *C. tropicalis* is known to be able to switch to true hyphal form, a capability that is probably much more restricted than in the case of *C. albicans* (Priest and Lorenz [@bib46]). The alternative genetic code of the CTG clade allows *C. albicans* to increase the diversity of its surface proteins, thus making it more difficult to detect by the immune system (Nather *et al.*[@bib40]; Miranda *et al.*[@bib36]). Little is known about the role in pathogenesis of this alternative codon in *C. tropicalis* and *C. parapsilosis.* Additionally, it is totally absent in the non-CTG clade species *C. glabrata*. Similarly, the response in face of the immune system of the different *Candida* species is highly variable. *Candida glabrata* shows adaptation to the conditions inside the phagosome and is able to live and even reproduce in this harsh environment during long periods of time (Fukuda *et al.*[@bib17]; Seider *et al.*[@bib54]). The other three species usually avoid phagocytosis in the first place, and switch to their hyphal or pseudohyphal stages in order to break free from phagocytic cells (Jiménez-López and Lorenz [@bib32]). *Candida glabrata* is also the only of the four that is a haploid, although parasexual cycle in *C. albicans* can produce aneuploidies that can result in partial haploidy (Glöckner and Cornely [@bib24]). *Candida glabrata* is also naturally resistant to azole compounds, and is the most common yeast to be able to acquire resistance to echinocandins (Pfaller and Diekema [@bib43]). In contrast to other *Candida* species, *C. glabrata* is more prevalent in adults, where aging, use of antibiotics and the severity of other medical conditions are important risk factors (Pfaller and Diekema [@bib43]; Guinea *et al.*[@bib26]). From the four, *C. parapsilosis* is the one that has lower lethality. It is also the only one that is not considered a human commensal and thus infections of *C. parapsilosis* are usually acquired from the environment and consistently avoided with proper preventive measures (Warnock [@bib62]; Holland *et al.*[@bib29]). *Candida parapsilosis* is mostly related to the use of catheters, prosthetics and other similarly invasive medical devices. Lastly, *C. tropicalis* infections are usually restricted to patients with neutropenia and other blood malignancies and usually respond to azole antifungals (Pfaller and Diekema [@bib43]; Guinea *et al.*[@bib26]). It is, however, more invasive than *C. albicans* and infections with this pathogen show higher mortality rates. Finally, beyond these generalities, the epidemiology of these fungal pathogens shows great variability among human populations and geographical regions (Pfaller and Diekema [@bib43]; Warnock [@bib62]; Guinea *et al.*[@bib26]).

In summary, the ability of *Candida* species to infect humans has emerged several times independently from each other from diverged non-pathogenic ancestors, and the extent to which they share virulence strategies is still an open question. From an evolutionary perspective, the parallel emergence of a common trait (i.e. the ability to infect humans) from different genomic backgrounds poses many intriguing questions: How many parallel adaptations emerged independently in more than one lineage? What set of genomic traits favored the emergence of virulence in each case? How many different paths may lead to the ability to infect humans? What evolutionary mechanisms have promoted the emergence of virulence? In the following sections, we provide an overview of recent studies that have addressed such and other questions in the main clades of pathogenic *Candida*.

GENOME VARIATION IN THE CTG CLADE AND EXPANSION OF CELL-WALL FAMILIES IN PATHOGENS {#sec4}
==================================================================================

One of the first studies targeting genomic variation in *Candida* pathogens was conducted by Geraldine Butler and collaborators in 2009 (Butler *et al.*[@bib7]). That study expanded the set of genome sequences of *Candida* pathogens (two by then *Candida albicans* and *C. glabrata*), by adding five new species, *C. tropicalis, C. parapsilosis*, *Lodderomyces elongisporus, C. guilliermondii* and *C. lusitaniae*, and a new strain of *C. albicans*. One of the first findings of the genome comparison was the discovery of large variations in genome size within the CTG clade (up to 50% variation in size), despite a similar gene repertoire size, with gene numbers ranging from 5733 to 6318. Importantly, this study provided the first hint for an enriched cell-wall repertoire in *Candida* pathogens, as compared to non-pathogenic relatives. By examining the phylogenetic distribution of 9209 gene families present across the analyzed species, they identified 21 which were enriched in the more common pathogens. These included families encoding GPI-anchored cell-wall adhesins, secreted lipases, as well as oligopeptide transporters, and transcription factors.

Among the families associated to the cell wall that were found to be expanded in pathogenic species, there were some, such as Hyr/Iff and Als adhesins, that were found to be duplicated in tandem in some pathogenic species, with the paralogous gene clusters sometimes including five or six genes of the same family. Tandem duplications are an essential source of genetic novelty that have been found to commonly underlie novel phenotypic traits, and are generally indicative of recent directional selection (Conant and Wolfe [@bib8]). In addition, these families were found to have high levels of sequence variation, including variations in number of intragenic tandem repeats. All these findings suggested that some virulence traits, such as an increased or more versatile adherence, may have emerged relatively fast by simple genome re-arrangements such as gene duplications followed by sequence divergence. An alternative approach identified 64 families likely subjected to positive selection in the lineages leading to highly pathogenic *Candida* species. Again, cell-wall proteins emerged in these analyses, together with families involved in hyphal and pseudohyphal filamentous growth, as well as in biofilm formation. Altogether, this study highlighted the importance of cell-wall components, probably mediating host--pathogen interactions, in shaping the ability to infect humans. Despite these important advances, the lack of close relatives for most of the pathogenic species included provided a limited resolution of the specificities of each pathogenic lineage.

The Butler *et al.* ([@bib7]) study also provided the first intraspecies genome comparison within a *Candida* pathogen, as it provided the genome sequence of a second strain belonging to a different Multilocus sequence type-based clade of *C. albicans*. The two strains were found to be highly colinear but they differed greatly in the extent of homozygous regions in their diploid genomes, indicating different events of loss of heterozygosity by break-induced recombination or recent passage through a parasexual cycle. More recent studies have increased our knowledge on the genetic variability at the species level in *C. albicans*, by analyzing the sequences of 21 independent clinical isolates (Hirakawa *et al.*[@bib28]) and 43 serial isolates from 11 distinct patients (Ford *et al.*[@bib16]). These analyses indicated that most genetic variation among *C. albicans* isolates corresponded to distinct patterns of loss of heterozygosis as well as total or partial chromosomal aneuploidies. These genomic changes underlaid important phenotypic variations such as up to 3-fold differences in growth rates, ability to filament or the resistance to antifungals. Importantly, these studies also showed that cell-wall proteins, including those mediating adhesion, were enriched among those gene families with accelerated evolutionary rates suggestive of positive selection. In the particular case of serial clinical isolates from patients undergoing azole treatments, loss of heterozygosity was found to be an important mechanism to mediate fast acquisition of reduced sensitivity to antifungals. In addition, point mutations affecting efflux pumps or drug targets appeared recurrently in isolates from several patients. However, it remains unclear whether this was the result of directional selection of standing variation in the patient\'s *Candida* population, or the result of the acquisition of novel mutations (Ford *et al.*[@bib16])**.**

THE *CANDIDA PARAPSILOSIS* COMPLEX AND A POTENTIAL ROLE OF HYBRIDIZATION {#sec5}
========================================================================

*Candida parapsilosis* was initially recognized as a single species and recently re-organized into three different species: *C*. *parapsilosis sensu stricto*, *C*. *orthopsilosis* and *C*. *metapsilosis*, respectively (Tavanti *et al.*[@bib58]). Notably, the three different species differ in their prevalence and their degree of virulence, *C. parapsilosis* being highly pathogenic and prevalent followed by *C. orthopsilosis*, and the least pathogenic and rarely isolated species *C. metapsilosis*. The first genome sequence of *C. parapsilosis* was provided by the above mentioned study (Butler *et al.*[@bib7]), and the main striking result was the low level of homozygosity of this genome, as compared to other diploid species in the same clade. In fact, *C. parapsilosis* presented only one heterozygous polymorphism per 15 553 bases, as compared to one every 200--600 in the other diploid species. Based on this finding and the fact that different *C. parapsilosis* strains are difficult to distinguish using standard molecular techniques (Tavanti *et al.*[@bib59]), it was later proposed that *C. parapsilosis* may have undergone a very recent population bottleneck (Sai *et al.*[@bib52]). In this context, it was also speculated that *C. parapsilosis* clinical isolates may represent a recent clonal expansion of a strain with increased virulence when compared with the closest relatives *C. orthopsilosis* and *C. metapsilosis* (Sai *et al.*[@bib52]). However, the sequencing of three additional isolates of clinical and environmental origins provided evidence against a recent clonal expansion in the clinical context (Pryszcz *et al.*[@bib47]). Indeed, a phylogenetic comparison of the clinical and environmental isolates showed that they were polyphyletic, suggesting multiple colonizations from the environment. In addition, all genomes analyzed, including those from clinical isolates, presented independent expansions (i.e. having different boundaries in the expanded segment) of a gene involved in arsenite resistance, which suggested recent directional selection in the environment rather than in the human body.

The first genome sequence of *C. orthopsilosis* was published in 2012 (Riccombeni *et al.*[@bib50]), and revealed a highly homozygous diploid genome. A comparison with the more pathogenic *C. parapsilosis* revealed that *C. orthopsilosis* had fewer copies of Als and Hyr/Iff families of cell-wall proteins, reinforcing the idea that the copy number of genes within these families may correlate with virulence. The sequencing of a second clinical *C. orthopsilosis* strain from Texas a few years later, however, was found to be highly heterozygous, with alternating blocks of homozygous and heterozygous genome regions (Pryszcz *et al.*[@bib48]). Importantly, heterozygous blocks were found to be composed of one haplotype virtually identical to the one of the previously sequenced strain, and another one showing a 4.5% divergence at the nucleotide level. Such level of divergence is high enough to correspond to a different species or subspecies, and it was concluded that this strain represented a hybrid. Even more striking was the finding that an independent clinical isolate from Singapore represented a virtually identical hybrid, suggesting a rapid global expansion of the hybrid lineage. In addition, as compared to the homozygous strain, the hybrid genome was found to have a higher number of copies of genes involved in virulence, suggesting that hybridization may have boosted its virulence.

The third and less virulent species of the complex, *C. metapsilosis*, was published in 2015 (Pryszcz *et al.*[@bib49]). Similar to the situation in the second published *C. orthopsilosis* genome, *C. metapsilosis* was found to be a hybrid between two lineages diverging 4.5% at the nucleotide level, and showing a chimeric genome with intercalated homozygous and heterozygous blocks. Here again, several globally distributed clinical isolates were found to derive from the same hybridization event, although in this case the 11 analyzed genomes were more divergent in terms of their patterns of homozygous and heterozygous blocks. The fact that the 11 analyzed *C. metapsilosis* isolates are hybrids descending from the same ancestor, and that none of the parental strains was present among the sequenced isolates strongly suggests that the parental lineages that formed this hybrid are not able to infect humans, and that the hybridization may have conferred this ability to the hybrids. Whether such hybrids can be found in nature or only associated to humans is still an open question, but the fact that the hybrids are somewhat divergent in their loss of heterozygosis patterns suggests they did not expand very recently. Altogether, these results argue for a new re-classification of the *C. parapsilosis* complex, in which at least five different lineages, or species, some of them with the ability to form hybrids exist. In addition, it raises the intriguing question of what role hybridization may play in the emergence of a virulent phenotype.

The impact of hybridization itself in pathogenicity is not fully understood, but there is evidence of hybridization in several other unrelated fungal human pathogens, such as *Cryptococcus neoformans* (Li *et al.*[@bib34]; Forche [@bib15]), *Coccidioides posadasi* (Neafsey *et al.*[@bib41]) and *Fusarium keratoplasticum* (Short, O\'Donnell and Geiser [@bib55]). Among plant pathogens, hybridization is increasingly being recognized as an important factor in the evolution of virulence (Depotter *et al.*[@bib10]). Hybrid strains may combine dangerous phenotypes of two or more strains, such as virulence factors or antifungal resistance; and its role in the emergence of new species as prevalent pathogens should not be underestimated. Even more, the classical chromosomic instability typically associated to hybridization may itself be advantageous during the course of infection, as it may help the pathogen to adapt to the immune system or different drugs. The possibility that patient-specific hybridization arise during the course of infections, for instance between acquired microbes and commensals, is intriguing and should be taken into account when studying the evolution of the infectious process. Such events may be responsible of a fraction of infections by rarer organisms and the origin of novel pathogenic strains. However, whether there is a real high prevalence of hybrid strains in pathogenic fungi or the long list of examples is the consequence of a bias in our knowledge remains unclear.

*CANDIDA GLABRATA* AND THE *NAKASEOMYCES* CLADE {#sec6}
===============================================

*Candida glabrata* was sequenced along with three other yeast species back in 2004 (Dujon *et al.*[@bib13]). Initial genome comparisons revealed that *C. glabrata* and *Saccharomyces cerevisiae* shared numerous blocks of duplicated genes implying that both species descended from the same tetraploid ancestor. However, as compared to *S. cerevisiae, C. glabrata* had fewer genes and a more compact genome, indicating a larger degree of genomic streamlining. Initial comparisons of both species with respect to their virulence potential identified the loss of some pathways such as that of the biosynthesis of nicotinic acid as a possible hallmark of adaptation to the human host (Roetzer, Gabaldón and Schüller [@bib51]). More recently, the five other known species of the *Nakaseomyces* clade, including the two less-prevalent emerging pathogens *C. bracarensis* and *C. nivarensis*, were fully sequenced and compared under an evolutionary framework (Gabaldón *et al.*[@bib21]). This analysis established that many of the differences between *C. glabrata* and *S. cerevisiae* were shared by other members of the clade implying that they were ancient traits unrelated with a commensal or pathogenic lifestyle. In addition, contrary to what may have been expected, the three pathogenic species of the clade where closely related but not monophyletic, suggesting multiple independent acquisitions of the ability to infect humans. Remarkably, the genome comparisons unearthed a large correlation between the number of copies of a particular family of epithelial adhesins (EPA) and the pathogenecity of the species. This family of cell-wall proteins mediates adhesion of *C. glabrata* cells to different substrates including host tissues, and constitutes a well-known virulence factor in *C. glabrata* (de Groot *et al.*[@bib9]). Interestingly, a closer phylogenetic analysis of the evolution of this family revealed that the larger size of the EPA repertoire in the pathogenic species corresponded to two independent expansions, one specific to *C. glabrata* and another one preceding the divergence of *C. bracarensis*, *C. nivarensis* and the non-pathogenic relative *Nakaseomyces delphensis*, which subsequently reduced its EPA repertoire. Altogether, these findings suggest two independent acquisitions of the ability to infect humans by means of increasing the strength or versatility of adhesion. In a broader context, it underscores the importance of increased adhesion in pathogens of different clades, which may have originated by expansions of different families of cell-wall adhesins.

The availability of a single genome sequence for *C. glabrata* limits the assessment of intraspecific variation to studies focusing on chromosomal aneuploidies or on few genetic markers (Muller *et al.*[@bib39]; Ahmad *et al.*[@bib1]; Bolotin-Fukuhara and Fairhead [@bib4]; Gabaldón and Carreté [@bib19]). These analyses have revealed significant variation among *C. glabrata* isolates, including copy number variations in several gene clusters and changes in karyotypes. Some studies have shown the appearance of novel chromosomes that seem to have originated by segmental duplications or genomic translocations (Ahmad *et al.*[@bib1]). Even phylogenetically related isolates, as well as those evolved under normal laboratory conditions have been shown to display significant chromosomal rearrangements that can be linked to certain phenotypic changes (Bader *et al.*[@bib3]; Ahmad *et al.*[@bib1]), suggesting that *C. glabrata* may frequently remodel its genome as a response to certain selective pressures.

CONCLUDING REMARKS AND FUTURE PROSPECTS {#sec7}
=======================================

The increasing availability of sequenced genomes from *Candida* pathogens and their close non-pathogenic relatives, and in some cases several genomes from each of the species, is having a clear impact on our understanding of how virulence appears and evolves across species. Phylogenetic analyses show that *Candida* pathogens are phylogenetically diverse, and that virulence has emerged multiple times among Saccharomycotina. It is anticipated that the whole taxonomy of the group will be reorganized to accommodate modern phylogenetic knowledge. In this regard most of the pathogenic species will have to be renamed, which will inevitably create confusion among clinicians and other researchers. At the same time, however, it may help to better understand their clearly different clinical and physiological traits. Genome comparisons are increasing our understanding of the similarities and specificities of each pathogen, which can often be correlated with different survival strategies within the host, and different behaviors in front of the host immune system or when faced with antibiotics. The closer analyses of the evolutionary path to virulence in the different *Candida* clades have revealed different evolutionary mechanisms, but strikingly similar patterns with respect to certain functional classes. In particular, the expansion of the cell-wall repertoire and more specifically of families involved in surface adhesion seems to be a common theme in most pathogenic clades analyzed. Yet, the specific families affected and the evolutionary mechanisms to achieve an expanded repertoire can differ broadly between clades. Thus different paths can lead to convergent properties of the cell surface such as a higher, or more versatile adherence.

Importantly, most of these adaptations seem to be driven by genomic re-arrangements involving duplications or hybridizations, which in one or a few steps can drive important phenotypic differences. This, in turn, suggests that the path to become an opportunistic pathogen is not a long one, but rather can be achieved by relatively few alterations from a non-pathogenic genetic background. Yet, some genetic backgrounds seem to be predisposed to cross that barrier. For instance, the presence of genes encoding adhesins in subtelomeric regions or other genomic locations prone to rearrangements may favor gene duplications, which would be selected in specific conditions. The role of hybridization deserves a special consideration, since human intervention, by altering the environment and promoting species invasions through global commerce and transport, may be favoring the appearance of new hybrids; some of which may have infective capabilities.

Despite recent progress, we are still far from understanding how virulence emerges and evolves across species. In this regard, population genomics approaches, as well as metagenomics hold the promise of increasing our knowledge on three fundamental questions that remain poorly addressed: (i) what are the recent selective pressures (at the species and population level) in human fungal pathogens? (ii) are opportunistic pathogens tightly adapted to humans, or do they colonize us from other niches in the environment? and (iii) what pre-adaptations in the environment favor a jump to an increase virulence in humans?
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